spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ROTATEQ 

 HSMN NewsFeed - 30 Jan 2020
SutroVax Announces Executive Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2015
Entasis Appoints Robin David Isaacs as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2013
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2010
Barry Buckland Joins Ancora Pharmaceuticals Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Feb 2007
Merck Updates Prescribing Information for ROTATEQ(R), the Company's Vaccine to Help Prevent Rotavirus Gastroenteritis in Infants and Children
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2006
Novavax Names Dr. Penny Heaton Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Biopharmaceuticals
 HSMN NewsFeed - 8 Jun 2006
FDA Approves Merck's GARDASIL(R), the World's First and Only Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 May 2006
Merck to Create New Patient Assistance Program for Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Feb 2006
GARDASIL(R), Merck's Investigational Cervical Cancer Vaccine, to Receive Priority Review from the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2006
FDA Approves Merck's ROTATEQ(R), The Only Vaccine in the U.S. to Prevent Rotavirus Gastroenteritis, a Leading Cause of Severe Infant Diarrhea
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jan 2006
AVANT Expands Senior Management Team with Appointment of Ronald W. Ellis, Ph.D., Senior Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2006
In a New Study Published in New England Journal of Medicine, ROTATEQ(R), Merck's Investigational Rotavirus Vaccine, Prevented 98 Percent of Severe Rotavirus Gastroenteritis
Biopharmaceuticals Gastroenterology
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
ROTATEQ
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.